Contact Us
Drug Search Results
More Filters [+]

Evenamide

Alternative Names: evenamide, NW-3509, NW3509, NW 3509
Latest Update: 2024-04-30
Latest Update Note: News Article

Product Description

Newron is developing Evenamide as a treatment for schizophrenia. (Sourced from: https://www.newron.com/news-and-media/regulatory-news/newron-announces-striking-six-month-interim-results-its-exploratory)

Mechanisms of Action: Voltage-Gated Sodium Channel Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Newron
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Evenamide

Countries in Clinic: India, United States

Active Clinical Trial Count: 5

Highest Development Phases

Phase 3: Bipolar Disorder|Schizophrenia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
Evenamide_020

P3

Active, not recruiting

Schizophrenia|Bipolar Disorder

2024-02-10

NW-3509/015/II/2019

P2

Active, not recruiting

Schizophrenia

2022-04-28

2020-006062-36

P3

Active, not recruiting

Schizophrenia

2022-03-30

NW-3509/014/II/2019

P2

Active, not recruiting

Schizophrenia

2022-02-24

Recent News Events

Date

Type

Title

04/30/2024

News Article

 Newron Announces Positive Top-line Results From Potentially Pivotal Phase II/III Study 008A With Evenamide in Schizophrenia Patients

04/08/2024

News Article

 Data from Newron's study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)

03/19/2024

News Article

 Newron Presents 2023 Financial Results and Provides 2024 Outlook

03/15/2024

News Article

 Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreement

10/01/2023

PubMed

 Synthesis and evaluation of alkoxy-substituted enamides against influenza A virus in vitro and in vivo.

09/18/2023

PubMed

 Metal-Free Stereoconvergent C-H Borylation of Enamides.

05/01/2023

PubMed

 Role of Molecular, Crystal, and Surface Chemistry in Directing the Crystallization of Entacapone Polymorphs on the Au(111) Template Surface.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions